North America Bispecific Antibodies Market Size & Outlook, 2025-2031
North America Bispecific Antibodies Market Size
According to Straits Research analysis, the North America Bispecific Antibodies Market was valued at USD 2244.2 Million in 2024 and is projected to reach USD 5489.27 Million by 2031, expanding at a CAGR of 14.5% during the forecast period. This market growth is attributable primarily to the rising prevalence of diseases like cancer and the growing demand from the pharmaceutical industry for new drug development. Key drivers include the advancement of biotechnology in healthcare and the escalating necessity for personalized medicine. Emerging opportunities like technological progress in genetic engineering and nanotechnology, offer potential for the development of more efficient and targeted bispecific antibodies. Given these factors, North America continues to strengthen its position in the market, positioning itself as a leader in the bispecific antibodies sector, catalyzed by its strong focus on health technology innovation and substantial investment in research and development.
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America Bispecific Antibodies Market Highlights
- Bi-specific T-cell engager represented the largest share of the Type market in terms of size in 2024.
- Among the Type segments, Bi-specific T-cell engager is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.
- In 2024, North America contributed 40.71% to the overall global bispecific antibodies market size.
- By 2031, United States is anticipated to dominate the global market based on market size.
- Canada is expected to witness the fastest growth within North America, attaining USD 132.59 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 2244.2 Million |
| Market Size In 2031 | USD 5489.27 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 14.5% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
North America Bispecific Antibodies Market By Country 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
